The metabolomics of asthma control: a promising link between genetics and disease

Short-acting β agonists (e.g., albuterol) are the most commonly used medications for asthma, a disease that affects over 300 million people in the world. Metabolomic profiling of asthmatics taking β agonists presents a new and promising resource for identifying the molecular determinants of asthma c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Immun Inflamm Dis
Huvudupphovsmän: McGeachie, Michael J, Dahlin, Amber, Qiu, Weiliang, Croteau-Chonka, Damien C, Savage, Jessica, Wu, Ann Chen, Wan, Emily S, Sordillo, Joanne E, Al-Garawi, Amal, Martinez, Fernando D, Strunk, Robert C, Lemanske, Robert F, Liu, Andrew H, Raby, Benjamin A, Weiss, Scott, Clish, Clary B, Lasky-Su, Jessica A
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578522/
https://ncbi.nlm.nih.gov/pubmed/26421150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.61
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk